Introduction: Recent advances in diagnostic modalities and therapeutic agents have raised
the importance of prognostic factors in predicting overall survival, as well as predictive …

To date, empirical literature has generally been considered lacking in relation to
neuroendocrine carcinomas (NECs), the highly malignant subgroup of neuroendocrine …

Pancreatic neuroendocrine tumors (PanNENs) are rare sporadic cancers or develop as part
of hereditary syndromes. PanNENs can be both functioning and non-functioning based on …

Neuroendocrine neoplasms (NENs) are a relatively rare group of heterogeneous tumours
originating from neuroendocrine cells found throughout the body. Pancreatic NENs …

Objective To describe paraneoplastic neuronal intermediate filament (NIF) autoimmunity.
Methods Archived patient and control serum and CSF specimens were evaluated by tissue …

Some biomarkers for functioning and non-functioning neuroendocrine neoplasms (NENs)
are currently available. Despite their application in clinical practice, results should be …

Abstract Background Pancreatic neuroendocrine tumors (PNETs) are a group of rare tumors.
Chromogranin A (CgA) was considered as the most practical and useful serum tumor marker …

DNA methylation contributes to malignant transformation, but little is known about how the
methylation drives colorectal cancer evolution at the early stages. Here we identify aberrant …

To help provide evidence for prognosis prediction and personalized targeted therapy for
patients with head and neck squamous cell carcinoma (HNSCC), we investigated prognosis …

Abstract Carbohydrate antigen 19‑9 (CA19‑9) is not generally considered to be a biomarker
in pancreatic neuroendocrine tumors (pNETs), as the majority of pNETs present with a …